NervGen Pharma Corp.
NGENF News Today: Stay Updated with the Latest NervGen Pharma Corp. News in Real Time
Find NGENF news now at Meyka AI. Stay informed with the latest NervGen Pharma Corp. stocks updates, including price news, market analysis, and expert insights.
Obayashi Corp May 24: Heat Wave Shifts Work Hours to 7AM-1PM
Obayashi Corp shifts work to 7AM-1PM during summer heat to protect workers and maintain efficiency amid Japan’s extreme temperatures.
Weekly Market Wrap: NIFTY50 Gains 0.3%, SENSEX Ends Higher; Grasim Industries and Wipro Lead Rally
The NIFTY50 ended the week on a mildly positive note, gaining 0.3% in the week ended Friday, May 22, 2026. The index added 75.80 points and closed at 23,719.30. The BSE SENSEX also moved higher, rising 0.24% or 177.36 points to settle at 75,415.35. These gains were modest, but they mattered because the broader market…
Highlander Silver Corp. (HSLV.CN) Trades at C$2.20 Amid Exploration Focus
HSLV.CN stock trades at C$2.20 with a market cap of C$231M. Highlander Silver explores silver-polymetallic projects in Peru.
LION Earnings Beat: Lionsgate Studios Corp. Crushes Q2 2026 Estimates
Lionsgate Studios Corp. (LION) beat Q2 2026 earnings on May 21, 2026, with EPS of $0.37 vs. $0.24 estimate and revenue of $906.5M vs. $811.7M.
XOMA Downgraded to Hold from Buy at Benchmark May 22
Benchmark downgraded XOMA to Hold from Buy on May 22, 2026. Stock trades at $41.65 with mixed analyst sentiment.
UAV Corp. Stock Surges 50% on Strategic Aerospace Merger Plan
UMAV stock jumps 50% after UAV Corp. signs MOU with Xeriant for potential merger and aerospace technology integration.
World Financial Split Corp. (WFS.TO) Surges 300% on Extreme Volatility
WFS.TO stock surges 300% to C$7.24 amid extreme trading volatility. Asset management fund shows dramatic price recovery from lows.
SPOD.CN Stock Surges 200% on Massive Volume Spike in Lithium Exploration Play
SPOD.CN stock jumps 200% with 2.26M shares traded. Exploration company holds Golden Moon and NW Abitibi projects in Canada.
Innate Pharma Stock Tumbles 16.3% as Biotech Faces Clinical Trial Headwinds
IPH.PA stock drops 16.3% to €1.64 on EURONEXT. Innate Pharma faces clinical trial delays and cash burn concerns in oncology pipeline.